Mary Hanson, PhD
Director, Scientific Affairs
Merck & Co., Inc.
2000 Galloping Hill Road
PO Box 539
Kenilworth,
NJ
USA
090333-1310
Papers:
2E-2
BEZLOTOXUMAB IS ASSOCIATED WITH A REDUCTION IN CUMULATIVE HOSPITALIZED DAYS: ANALYSIS OF THE HOSPITALIZATION DATA FROM THE MODIFY I AND II CLINICAL TRIALS